Advertisement

Topics

Presbia Announces Completion of Rights Offering

16:15 EDT 13 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announces the final closing of its rights offering, which expired on March 8, 2017 and raised aggregate gross proceeds of $10.8 mill...

Other Sources for this Article

Presbia PLC
Jarett Fenton, 949-502-7036
jfenton@presbia.com

NEXT ARTICLE

More From BioPortfolio on "Presbia Announces Completion of Rights Offering"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...